Rosuvastatin on Diabetic Patients Treated With Glimepiride/Metformin
Status:
Completed
Trial end date:
2021-01-31
Target enrollment:
Participant gender:
Summary
study effects of rosuvastatin on markers of atherosclerosis, thrombosis, in diabetic patients
treated with glimepiride/metformin without coronary artery disease.
This effect will be investigated especially on sortilin ,fetuin-A